Compartilhar
Informação da revista
Número
Vol. 43. Núm. S3.Páginas Z1-Z6 (novembro 2021)
Speaker presentations
Speaker presentations
Pediatric presentations
Oral presentations
THE IMPACT OF TYROSINE KINASE INHIBITORS ON FATHERHOOD IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA, A SINGLE INSTITUTION EXPERIENCE
Mohammad Abu-Tineh, Awni Alshurafa, Elrazi Awadelkarim Hamid Ali, Ashraf Omer Elamin Ahmed, Khalid Mohamed Ibrahim Alhaj ALbsheer, Yousef Hailan, Waail Rozi, Abdulqader Nashwan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S15
Open access
CLINICAL CHARACTERISTICS, AND SURVIVAL RATE OF ELDERLY PATIENTS WITH NON-HODGKIN'S LYMPHOMAS WITH PRIMARY INVOLVEMENT OF PERIPHERAL LYMPH NODES
Tomacinschii Victor, Buruiana Sanda, Robu Maria
Hematol Transfus Cell Ther. 2021;43 Supl 3:S16
Open access
UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT
Carlos CHIATTONE, Eliana MIRANDA, Marcia DELAMAIN, Juliana PEREIRA, Natalia ZING, Danielle FARIAS, Guilherme DUFFLES, Marcelo BELLESSO, ... Carmino SOUZA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S16-S17
Open access
IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
Senem Maral, Murat Albayrak, Gülten Korkmaz, Simten Dagdas, Berna Afacan Öztürk, Aynur Albayrak, Ünsal Han, Merih Reis Aras, Gülsüm Özet
Hematol Transfus Cell Ther. 2021;43 Supl 3:S17
Open access
INVESTIGATION OF THE QUALIFICATION OF RADIOLOGICAL TECHNIQUES TO DETECT OSTEOLYTIC LESIONS, FRACTURES, AND OSTEOPOROSIS IN MULTIPLE MYELOMA PATIENTS
Atakan Turgutkaya, İrfan Yavaşoğlu, Tuğba Şahin, Ali Zahit Bolaman
Hematol Transfus Cell Ther. 2021;43 Supl 3:S17-S18
Open access
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
Mehmut TURGUT, Roman HAJEK, Tomas JELÍNEK, Philippe MOREAU, Thomas MARTIN, Ludek POUR, Gabor MIKALA, Argiris SYMEONIDIS, ... Ivan SPICKA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S18
Open access
DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
Waail Rozi, Elrazi Ali, Alaa Rahhal, Abdulrahman Al-Mashdali, Yousef Hailan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19
Open access
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, ... Mesut TIĞLIOĞLU
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19-S20
Open access
AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B
Özden ÖZLÜK, Metban GÜZEL MASTANZADE, Beyza ŞEN OLUK, Sevgi KALAYOĞLU BEŞIŞIK, Bezirgen BALLYYEV
Hematol Transfus Cell Ther. 2021;43 Supl 3:S20
Open access
B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
Svetlana Chulkova, Nikolai Tupitsyn
Hematol Transfus Cell Ther. 2021;43 Supl 3:S21
Open access
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
Barış YILMAZ, Ahmet KOÇ, Ömer DOĞRU, Burcu TUFAN TAŞ, Rabia Emel ŞENAY, Nurşah EKER, Ayşe Gülnur TOKUÇ
Hematol Transfus Cell Ther. 2021;43 Supl 3:S22
Open access
JUVENILE MYELOMONOCYTIC LEUKEMIA SINGLE CENTER EXPERIENCE
Yunus Murat Akcabelen, Dilek Kaçar, Ayça Koca Yozgat, Özlem Arman Bilir, Dilek Gürlek Gökçebay, Turan Bayhan, İkbal Ok Bozkaya, Namık Yaşar Özbek, Neşe Yaralı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S25
Open access
THE FREQUENCY OF HLA-A, B AND DRB1 ALLELES IN PATIENTS WITH BETA THALASSEMIA
Zeynep Karakas, Yasin Yilmaz, Ayse Erol, Demet Kivanc, Mediha Suleymanoglu, Hayriye Senturk Ciftci, Cigdem Cinar, Serap Karaman, ... Fatma Savran Oguz
Hematol Transfus Cell Ther. 2021;43 Supl 3:S26-S27
Open access
EVALUATION OF APPROPRIATE USE OF PEDIATRIC FRESH FROZEN PLASMA IN A TERTIARY CARE HOSPITAL
Dilek GURLEK GOKCEBAY, Aslı TURGUTOGLU YILMAZ, Beytullah Şantaflıoğlu, İkbal Ok Bozkaya, Neşe Yaralı, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S28
Open access
COMPARABLE OUTCOMES OF ALLOGENEIC PERIPHERAL BLOOD VERSUS BONE MARROW HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
AYÇA KOCA YOZGAT, ÖZLEM ARMAN BİLİR, İKBAL OK BOZKAYA, MELTEM ÖZGÜNER, NAMIK YAŞAR ÖZBEK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S28
Open access
BURKITT LYMPHOMA PRESENTING WITH EYE AND KIDNEY INVOLVEMENT: CASE REPORT
Aslı Turgutoğlu Yılmaz, Derya Ozyoruk, Neriman Sarı, F.Burcin Kurtipek, Arzu Erdem, Selma Cakmakci, Sonay Incesoy, Inci Ilhan Ergurhan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S29
Open access
NECESSITY FOR A CUSTOMIZED NGS PANEL FOR ACCURATE DIAGNOSIS AND TARGETED THERAPIES IN PEDIATRIC GLIAL TUMORS
Ayça Erşen Danyeli, Cengiz Yakıcıer, Bahattin Tanrıkulu, Cengiz Canpolat, M. Memet Özek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S29
Open access
EVALUATION OF CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH RHABDOID TUMOR: A MULTICENTER STUDY
Firdevs AYDIN, Can ACIPAYAM, Defne AY TUNCEL, Kemal DENİZ, Süreyya Burcu GÖRKEM, Veysel GÖK, Alper ÖZCAN, Ebru YILMAZ, ... Mehmet Akif ÖZDEMİR
Hematol Transfus Cell Ther. 2021;43 Supl 3:S31
Open access
Poster presentations
VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
Melda Cömert, Tuba Bulduk, Bilge Uğur, Murat Yıldırım, Selim Sayın, Alparslan Merdin, Ebru Kılıç Güneş, Elifcan Aladağ Karakulak, Meltem Aylı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S33-S34
Open access
A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
David MARKS, Marcos DE LIMA, Partow KEBRIAEI, Francesco LANZA, Christina CHO, Sergio GIRALT, Gizelle POPRADI, Michael HEMMER, ... Wael SABER
Hematol Transfus Cell Ther. 2021;43 Supl 3:S34
Open access
ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT
Senem MARAL, Murat ALBAYRAK, Hacer Berna OZTURK, MerihREIS ARAS, Fatma YILMAZ, Pınar TIGLIOGLU, Mesut TIGLIOGLU, Buğra SAGLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S34-S35
Open access
INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT
Merih Reis Aras, Senem Maral, Hacer Berna Afacan Ozturk, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Mustafa Onder, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S36
Open access
T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
Merih Reis Aras, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Neslihan Olgun, Senem Maral, Hacer Berna Afacan Ozturk, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S36
Open access
THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE
Elrazi Ali, Mohammad Abu-Tineh, Anas Babiker, Yousef Hailan, Bashir Ali, Qusai Maharmah, Zakaria Maat, Abdulatif Waggad, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S39
Open access
CONCOMITANT JAK2 AND BCR-ABL1 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA CLINICAL IMPACT AND RESPONSE TO THERAPY: A SYSTEMATIC REVIEW
Elrazi Ali, Elabbass Abdelmahmuod, Mohamed Yassin, Ashraf Ahmed, Maab Faisal
Hematol Transfus Cell Ther. 2021;43 Supl 3:S39
Open access
DOUBLE HETEROZYGOTIC FV DEFECT WITH HETEROZYGOTIC FV LEIDEN MUTATION AND FV DEFICIENCY IN THROMBOSIS
İSMAİL ALTUĞ DEMİR, HATİCE DEMET KİPER ÜNAL, ŞERİFE SOLMAZ, BAHRİYE PAYZIN, TUĞBA ÇETİNTEPE
Hematol Transfus Cell Ther. 2021;43 Supl 3:S39-S40
Open access
BLEEDING MANAGEMENT DURING DELIVERY AND POSTPARTUM PERIOD IN GLANZMANN THROMBASTHENIA: EXPERIENCES FROM TWO CASES
Özden ÖZLÜK, Mustafa Murat ÖZBALAK, Tarık Onur TİRYAKİ, Sevgi KALAYOĞLU BEŞIŞIK, Tuba SARAÇ SİVRİKOZ
Hematol Transfus Cell Ther. 2021;43 Supl 3:S40
Open access
CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER
Mesut Tığlıoğlu, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S40
Open access
ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE
Alfadil Haroon, Ali Alahmari, Nadiah Alobaidi, Ahmed Syed Osman, Hazzaa Alzahrani
Hematol Transfus Cell Ther. 2021;43 Supl 3:S40-S41
Open access
A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA
Fatma YILMAZ, Murat ALBAYRAK, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Merih REİS ARAS, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S41-S42
Open access
A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
Mesut Tığlıoğlu, Murat Albayrak, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk
Hematol Transfus Cell Ther. 2021;43 Supl 3:S42-S43
Open access
CLINICAL PARAMETERS OF MULTIPLE MYELOMA PROGRESSION IN RESIDENTS OF THE GOMEL REGION OF BELARUS
Zhanna KOZICH, Victor MARTINKOV, Janna PUGACHEVA, Ludmila SMIRNOVA, Svetlana MIHNO, Anna DOMANTSEVICH
Hematol Transfus Cell Ther. 2021;43 Supl 3:S44
Open access
A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME
Buğra Sağlam, Murat Albayrak, Mustafa Önder, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral
Hematol Transfus Cell Ther. 2021;43 Supl 3:S45-S46
Open access
INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, ... Hilde De Winter
Hematol Transfus Cell Ther. 2021;43 Supl 3:S46-S47
Open access
EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS
Ayoade Adeyemi, Filip Callewaert, Francesca Razakariasa, Rui de Passos Sousa
Hematol Transfus Cell Ther. 2021;43 Supl 3:S47
Open access
THE ROLE OF SUBPOPULATIONS OF MOBILIZED PERIPHERAL HEMATOPOIETIC STEM CELLS IN THE RESTORATION OF HEMATOPOIESIS DURING HIGH-DOSE CHEMOTHERAPY IN CANCER PATIENTS
Liudmila GRIVTSOVA, Nikolai TUPITSYN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S47-S48
Open access
THERAPEUTIC PLASMA EXCHANGE IN PATIENTS WITH NEUROLOGICAL DISEASES: A 9-YEAR, SINGLE-CENTER EXPERIENCE
Merih Reis Aras, Mehlika Panpalli Ates, Murat Albayrak, Hacer Berna Afacan Ozturk, Abdulkerim Yildiz, Fatma Yilmaz, Bugra Saglam, Selim Selcuk Comoglu
Hematol Transfus Cell Ther. 2021;43 Supl 3:S49
Open access
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50
Open access
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50
Open access
EXTRAMEDULLARY HEMATOPOIESIS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (TDT): A SYSTEMATIC REVIEW
Eihab Subahi, Fateen Ata, Hassan Choudry, Phool Iqbal, Mousa AlHiyari, Ashraf Soliman, Vincenzo De Sanctis, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50-S51
Open access
A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION
Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S51
Open access
WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Sevda SERT EKINCI, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, ... Sevgi KALAYOGLU BESISIK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52
Open access
A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA
Buğra Sağlam, Murat Albayrak, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52-S53
Open access
ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
Yunus Murat Akcabelen, Volkan Köse, Dilek Gürlek Gökçebay, Turan Bayhan, Neşe Yaralı, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S54
Open access
THE EVALUATION OF HEALTHY CHILDREN WITH INCIDENTAL PROLONGATION OF PROTHROMBIN OR ACTIVATED PARTIAL THROMBOPLASTIN TESTS
Gökcen MERAL, Volkan KÖSE, Vildan ÇULHA, AYÇA KOCA YOZGATLI, NAMIK YAŞAR ÖZBEK, HÜSNİYE NEŞE YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S55
Open access
CHILDHOOD IMMUNE THROMBOCYTOPENIA: A MULTICENTER QUESTIONNAIRE STUDY
Ayşegül Ünüvar, Melike Sezgin Evim, Serap Karaman, Arzu Akçay, İbrahim Eker, Funda Tayfun Küpesiz, Namık Özbek, Mehmet Ertem, ... Hale Ören
Hematol Transfus Cell Ther. 2021;43 Supl 3:S55-S56
Open access
CHARACTERISTICS AND OUTCOME OF T(8;21)-POSITIVE CHILDHOOD ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION'S EXPERIENCE
Volkan KÖSE, Dilek KAÇAR, Özlem ARMAN BİLİR, Ayça KOCA YOZGAT, Hüsniye Neşe YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S58
Open access
BK-VIRUS ASSOCIATED HAEMORRHAGIC CYSTITIS CONCOMITANT WITH CHEMOTHERAPY IN AN ADOLESCENT GIRL WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Aslı Turgutoğlu Yılmaz, Dilek Kacar, H. Nese Yarali, Namik Yasar Ozbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S58
Open access
BONE AS A SITE OF EXTRAMEDULLARY DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
Fatma Tuba YILDIRIM, Dilek KAÇAR, Aslı TURGUTOĞLU YILMAZ, Burçin KURTİPEK, Ayça KOCA YOZGAT, Dilek GÜRLEK GÖKÇEBAY, Neşe YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S59
Open access
PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
Serap Karaman, Mustafa Bilici, Ayşegül Ünüvar, Deniz Tuğcu, Gülşah Tanyıldız, Rumeysa Tuna Deveci, Gülçin Yegen, Şifa Şahin, Zeynep Karakaş
Hematol Transfus Cell Ther. 2021;43 Supl 3:S60-S61
Open access
INVESTIGATION OF SALIVARY miR-9, miR-34a ve miR-196a LEVELS IN FANCONI ANEMIA AND ORAL SQUAMOUS CELL CARCINOMA PATIENTS
Zisan Asal Kilic, Nevin Yalman, Tulin Tiraje Celkan, Bora Basaran, Haydar Murat Yener, Selcuk Dasdemir, Mehmet Güven Günver
Hematol Transfus Cell Ther. 2021;43 Supl 3:S61
Open access
A NOVEL MISSENSE MUTATION OUTSIDE DNAJ DOMAIN OF DNAJC21 IS ASSOCIATED WITH SHWACHMAN-DIAMOND SYNDROME
Mohammad Bilal Alsavaf, Jeffrey M. Verboon, Muhammed E. Dogan, Zehra Busra Azizoglu, Fatma Zehra Okus, Alper Ozcan, Munis Dundar, Ahmet Eken, ... Ekrem Unal
Hematol Transfus Cell Ther. 2021;43 Supl 3:S61-S62
Open access
THE ROLE OF THERAPEUTIC DRUG MONITORING OF INTRAVENOUS BUSULFAN FOR PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME IN CHILDREN
Dilek GURLEK GOKCEBAY, ÖzlemArman Bilir, Seda Şahin, İkbal Ok Bozkaya, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S62
Open access
A CASE OF POLYCYTHEMIA DIAGNOSED AS HEMOGLOBIN ANDREW-MINNEAPOLIS
Mustafa Bilici, Serap Karaman, Aysegul Unuvar, Deniz Tugcu, Gülsah Tanyildiz, Ayca Dilruba Aslanger, Oya Uyguner, Rumeysa Tuna Deveci, ... Zeynep Karakas
Hematol Transfus Cell Ther. 2021;43 Supl 3:S62-S63
Open access
HIGH GRADE GLIOMA OF CENTRAL NERVOUS SYSTEM: SINGLE CENTER TREATMENT EXPERIENCE
Nur OLGUN, Deniz KIZMAZOGLU, Batuhan OZDOGAR, Dilek INCE, Emre CECEN, Ceren KIZMAZOGLU, Şefika AKYOL, Ayşe DEMIRAL, ... Erdener OZER
Hematol Transfus Cell Ther. 2021;43 Supl 3:S63-S64
Open access
ACTINOMYCES ODONTOLYTICUS: A RARE CAUSE OF PEDIATRIC FEBRILE NEUTROPENIA
Meric KAYMAK CIHAN, Sonay INCESOY OZDEMIR, Belgin GULHAN, Arzu YAZAL ERDEM, Derya OZYORUK, Neriman SARI, Inci ERGURHAN ILHAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S65
Open access
WITHDRAWN: THE EFFECT OF NIVOLUMAB IN PEDIATRIC MALIGNANT TUMORS: A SINGLE CENTER EXPERIENCE WITH EIGHT PATIENTS
Veysel GOK, Firdevs AYDIN, Alper OZCAN, Ebru YILMAZ, Ekrem UNAL, Musa KARAKUKCU, Türkan PATIROGLU, Mehmet Akif OZDEMIR, ... Atil BISGIN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S65
Open access
Speaker presentations
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.